|Articles|April 1, 2016
- Applied Clinical Trials-04-01-2016
- Volume 25
- Issue 4
Applied Clinical Trials, April/May 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials April/May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
Califf: More Informative Clinical Research Key to Drug Developmentover 10 years ago
EMA Releases New Advice on Human Trials for Cancer Drugsover 10 years ago
Number of Countries in Phase III Studies Remains Steadyover 10 years ago
Will EMA Rules Calm the Disclosure Debate?over 10 years ago
Acknowledging Cycle Time Impact from Protocol Amendmentsover 10 years ago
The Promise of Precision Medicineover 10 years ago
Value-Based Planning & Drug Development Productivityover 10 years ago
Overcoming Early Phase Oncology Challengesover 10 years ago
Imagining the Impossible: Immunity to CancerAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
2
When the Slack Runs Out: AI and the CRO Operating Model
3
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5